# FDA Inspection 1182271 - John Rubino, MD - October 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/john-rubino-md/4aafbeb2-4036-4d7d-b4e7-9427cd3c5a5c
Source feed: FDA_Inspections

> FDA Inspection 1182271 for John Rubino, MD on October 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182271
- Company Name: John Rubino, MD
- Inspection Date: 2022-10-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 930218 - 2015-06-15](https://www.keypedia.com/records/fda_inspections/john-rubino-md/a5740fb0-ff9b-40ae-afe3-b44423b162ad)
- [FDA Inspection 847203 - 2013-09-06](https://www.keypedia.com/records/fda_inspections/john-rubino-md/13257b8e-7409-468c-91d2-a8eb06451185)

Company: https://www.keypedia.com/companies/john-rubino-md/7346f93e-7535-4015-b84b-a57c1ff8d28f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c